학술논문
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
Document Type
Article
Author
Blay, Jean-Yves ; Chevret, Sylvie; Le Cesne, Axel; Brahmi, Mehdi; Penel, Nicolas; Cousin, Sophie; Bertucci, Francois; Bompas, Emmanuelle; Ryckewaert, Thomas; Soibinet, Pauline; Boudou-Rouquette, Pascaline; Saada Bouzid, Esma; Soulie, Patrick; Valentin, Thibaud; Lotz, Jean-Pierre; Tosi, Diego; Neviere, Zoé; Cancel, Mathilde; Ray-Coquard, Isabelle; Gambotti, Laetitia; Legrand, Frédéric; Lamrani-Ghaouti, Assia; Simon, Clotilde; Even, Caroline; Massard, Christophe
Source
In The Lancet Oncology August 2023 24(8):892-902
Subject
Language
ISSN
1470-2045